APOA1 and obesity due to melanocortin 4 receptor deficiency: This observation may further underline the role that anti-apoA-1 antibodies have in the pathophysiology of atherosclerotic CVD in obesity and the reduction of these antibodies may be a mechanism by which CVD is reduced post-bariatric surgery.